Page 90 - GPD-4-2
P. 90

Gene & Protein in Disease                                              Regulatory elements of ATP7B in WD



            that provides valuable data on tissue- and cell-specific gene   diagnosis for clinicians. We hypothesized that
            expression and regulation across different individuals,   hypomorphic alleles in key copper-metabolizing genes
            developmental stages, and species.                 other than ATP7B may contribute to the WD phenotype,
                                                               potentially resulting in atypical or milder symptoms
            2.5. Statistical analysis
                                                               compared to patients with two ATP7B mutated alleles.
            The age of onset, serum ceruloplasmin levels, and 24-h   Thus, we compared the clinical features and the age of
            urinary copper levels were compared between the WD   onset between three groups of patients: those with (i) no
            patients with no coding mutation, a single mutated allele,   ATP7B mutations, (ii) a single mutated ATP7B allele, and
            and both mutations of ATP7B using an unpaired Student’s   (iii) mutations in both alleles. However, no significant
            t-test. P < 0.05 were considered statistically significant.  differences  were  observed between  the  groups when

            3. Results and discussions                         comparing the age of onset, serum ceruloplasmin
                                                               levels,  and  24-h  urinary  copper  levels  using  unpaired
            3.1. Comparison of clinical features of WD patients  Student’s  t-test with Welch’s correction (Figure  1).
            WD patients often exhibit overlapping clinical     The clinical features of all the patients are detailed in
            symptoms with other early-onset diseases, complicating   Tables S2 and S3.

                        A                                B




















                        C                      D                        E



















            Figure 1. Comparison of clinical parameters between Wilson’s disease patients with no mutation, single allelic mutation, and both coding mutations
            in ATP7B. (A) Number of males and females among WD patients. (B) Number of individuals with neurological, hepatic, and neurological and hepatic
            symptoms. (C) Comparison of 24-h urinary copper level  (µg/24  h) between the groups using unpaired Student’s  t-test. (D) Comparison of serum
            ceruloplasmin levels (mg/dL) between the groups using unpaired Student’s t-test with Welch’s correction. (E) Comparison of age at the onset of symptoms
            between the groups of WD patients using unpaired Student’s t-test with Welch’s correction. P<0.05 was considered statistically significant. Analysis was
            performed using available clinical information.
            Abbreviations: Neuro + Hep: Neurological with hepatic symptoms; ns: Not significant; WD: Wilson’s disease.



            Volume 4 Issue 2 (2025)                         4                               doi: 10.36922/gpd.7503
   85   86   87   88   89   90   91   92   93   94   95